Lamb Weston (LW) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Dec, 2025Executive summary
Focus to Win strategy and cost savings drove customer partnerships, operational improvements, and share gains, with volume up 8% in Q2 and 7% for the first half, especially in North America and Asia.
Net sales for Q2 2026 rose 1% year-over-year to $1,618.1 million, with volume gains offset by an 8% decline in price/mix; foreign currency provided a $24.4 million benefit.
Cost savings initiatives improved manufacturing costs and reduced SG&A, supporting margin resilience.
Board authorized a 3% increase in the quarterly dividend, continuing annual increases since IPO.
Restarted previously curtailed North American production lines to meet higher demand.
Financial highlights
Q2 net sales: $1,618.1M (up $17.2M YoY); volume up 8%, price/mix down 8%; gross profit: $324.3M (up $46.5M YoY); adjusted EBITDA: $285.7M (down $8.5M YoY); net income: $62.1M (vs. $(36.1)M YoY).
Free cash flow for 1H FY26 was $375M; net cash from operations was $530.4M, up $101.1M YoY.
Capital expenditures for 1H FY26 were $155.7M, down $330.7M from prior year.
North America Adjusted EBITDA rose $18.6M to $287.8M; International Adjusted EBITDA fell $21.4M to $27.2M.
Q2 gross margin: 20.1% (up from 17.4% YoY); effective tax rate: 36.7% (vs. (59.0)% YoY).
Outlook and guidance
Fiscal 2026 net sales guidance reaffirmed at $6.35–$6.55 billion; adjusted EBITDA expected at $1.00–$1.20 billion, with expectations to finish near the midpoint.
Capital expenditures for fiscal 2026 projected at approximately $500 million; interest expense ~$190M; D&A ~$390M; tax rate 28–29%.
Guidance includes current tariffs but excludes potential future trade policy changes.
North America volumes expected to grow at or above first-half rates; International volumes to be flat year-over-year in the second half.
Price/mix headwinds to persist but moderate in the second half; Adjusted Gross Margin expected flat to down versus first half's 20.4%.
Latest events from Lamb Weston
- Q3 FY25 sales up 4% with higher volume, cost savings, and reaffirmed guidance amid headwinds.LW
Q3 20254 Feb 2026 - Q4 sales rose 4% with cost savings; 2026 outlook focuses on efficiency and cash flow.LW
Q4 20254 Feb 2026 - Q4 profit plunged on soft demand, share losses, and product withdrawal; FY25 outlook cautious.LW
Q4 20243 Feb 2026 - Net income fell 46% as restructuring and cost actions target $55M in FY25 savings.LW
Q1 202519 Jan 2026 - Q2 FY25 results missed expectations, with lower sales, a net loss, and reduced full-year guidance.LW
Q2 202510 Jan 2026 - Board refresh, CEO transition, and pay-for-performance drive strategic and governance changes.LW
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, highlighting governance, pay, and ESG focus.LW
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and officer exculpation amendment.LW
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, auditor ratification, and officer exculpation.LW
Proxy Filing1 Dec 2025